DEPAKIMENr CF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATICNAL INSTITUTES CF HEALTH 
RECCMBINANT ADVISORY CCMMITTEE 
MINUTES CF MEETINSl 
FEBRLARY 8-9, 1982 
Hie Reocmbinant ENA Advisory Committee (RAC) v«s convened for its twenty-fourth 
meeting at 9:00 a.m. on FdDruary 8, 1982, at the Marriott Hotel, Salon D and E, 
5151 Rocks Hill Road, Bethesda, Maryland 20814. Mr. R^ Ttornton (Chairman), 
President, Arkansas State Uhiversity, presided. In accordance with Public Law 
92-463, the meeting was open to the public. 
Committee members present for all or part of the meeting were; 
Abdul Karim Ahmed; David Baltimore; Kenneth Bems; L. Albert Ealoz; Nina Fedoroff; 
David Friedman; Richard Goldstein; King Holmes; I^tricia King; Arthur Landy; f^on 
Levine; Vfemer Maas; David Martin; James Mason; Gerard MoGarrity; Robert McKinney; 
Robert Mitchell; Elena Nightingale; Ramon Pinon; Mark Saginor; Johi Scandalios; 
and William J. Gartland, Jc., Executive Secretary. 
A Coimittee roster is attached. (Attachment I) 
The following ad hoc consultant to the Conmittee was present; 
Susan K. Qottesnan, National Institutes of Health. 
The following noT-voting members and liaison representatives were present; 
Howard Beman, U.S. \feterans Administration; Chia T. Chen, OSHA, U.S. Department 
of labor; George Duda, Department of Energy; Timothy J. Henry, Pood and Drug 
Administration; Herman Lewis, National Science Foundation; Henry Miller, Bureau 
of Drugs, FDA; Sue Tblin, U.S. Department of Agriculture; and William J. Walsh, 
III, U.S. Department of State. 
^Hie RAC is advisory to the NIH, and its recommendations should not be considered 
as final and accepted. The Office of Recombinant ENA Activities should be con- 
sulted for NIH policy on specific issues. 
[ 330 ] 
